Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2022-03-07 Taylor Stacy L SVP and General Counsel Sale −1,569 $12.01 $19K 75,246
2022-03-07 PISKEL KYLE Principal Accounting Officer Sale −220 $12.01 $3K 47,665
2022-03-07 LO FRANCIS Chief People Officer Sale −1,569 $12.01 $19K 93,170
2022-03-07 ROBINS HARLAN S Chief Scientific Officer Sale −4,517 $12.01 $54K 311,960
2022-03-07 ROBINS CHAD M CEO and Chairman Sale −4,424 $12.01 $53K 1,916,154
2022-03-07 ADAMS R MARK Chief Operating Officer Sale −1,244 $12.01 $15K 123,724
2022-03-04 SOOD NITIN Chief Commercial Officer Grant or award +65,898 163,111
2022-03-04 SOOD NITIN Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +164,745 164,745
2022-03-04 RUBINSTEIN JULIE President Grant or award +185,338 231,126
2022-03-04 RUBINSTEIN JULIE President Grant or award · Stock Option (Right to Buy) +463,344 463,344
2022-03-04 BENZENO SHARON Chief Business Development Off Grant or award +82,372 105,266
2022-03-04 BENZENO SHARON Chief Business Development Off Grant or award · Stock Option (Right to Buy) +205,931 205,931
2022-03-04 Taylor Stacy L SVP and General Counsel Grant or award +61,779 76,815
2022-03-04 Taylor Stacy L SVP and General Counsel Grant or award · Stock Option (Right to Buy) +154,448 154,448
2022-03-04 PISKEL KYLE Principal Accounting Officer Grant or award +41,186 47,885
2022-03-04 PISKEL KYLE Principal Accounting Officer Grant or award · Stock Option (Right to Buy) +102,965 102,965
2022-03-04 LO FRANCIS Chief People Officer Grant or award +74,135 94,739
2022-03-04 LO FRANCIS Chief People Officer Grant or award · Stock Option (Right to Buy) +185,338 185,338
2022-03-04 ROBINS HARLAN S Chief Scientific Officer Grant or award +247,117 316,477
2022-03-04 ROBINS HARLAN S Chief Scientific Officer Grant or award · Stock Option (Right to Buy) +617,792 617,792

Page 36 of 120 · 2,386 trades